<DOC>
	<DOCNO>NCT00702676</DOCNO>
	<brief_summary>This study compare tolerability Quetiapine Fumarate immediate release formulation Quetiapine Fumarate extend release formulation initial dose escalation healthy volunteer .</brief_summary>
	<brief_title>Quetiapine Fumarate Immediate Release ( IR ) Versus Extended Release ( XR ) Dose Escalation Comparison</brief_title>
	<detailed_description />
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>Provision inform consent prior study specific procedure Weight least 50 kg A history presence neurological , hematological , psychiatric , gastrointestinal , hepatic , pulmonary , renal disease condition know interfere absorption , distribution , metabolism , excretion drug Positive test result alcohol drug abuse Positive test result human immunodeficiency virus ( HIV ) , hepatitis B surface antigen ( HBsAg ) , hepatitis C antibody</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>Healthy Volunteers</keyword>
</DOC>